tiprankstipranks
Trending News
More News >
Arbutus Biopharma (ABUS)
:ABUS
US Market

Arbutus Biopharma (ABUS) Income Statement

Compare
1,266 Followers

Arbutus Biopharma Income Statement

Last quarter (Q3 2025), Arbutus Biopharma's total revenue was $529.00K, a decrease of -60.49% from the same quarter last year. In Q3, Arbutus Biopharma's net income was $-7.74M. See Arbutus Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 6.17M$ 18.14M$ 39.02M$ 10.99M$ 6.91M
Gross Profit
$ 6.17M$ 18.14M$ 39.02M$ 10.99M$ -40.57M
Operating Expenses
$ 82.49M$ 96.24M$ 104.47M$ 84.51M$ 17.24M
Depreciation and Amortization
$ 1.38M$ 1.40M$ 1.43M$ 1.75M$ 1.98M
EBITDA
$ -68.40M$ -70.99M$ -61.86M$ -71.64M$ -57.76M
Operating Income
$ -76.32M$ -78.10M$ -65.46M$ -73.52M$ -57.81M
Other Income/Expenses
$ 6.40M$ 5.25M$ 444.00K$ -2.73M$ -5.94M
Pretax Income
$ -69.92M$ -72.85M$ -65.01M$ -76.25M$ -63.74M
Net Income
$ -69.92M$ -72.85M$ -69.46M$ -76.25M$ -63.74M
Per Share Metrics
Basic EPS
$ -0.38$ -0.44$ -0.46$ -0.73$ -0.86
Diluted EPS
$ -0.38$ -0.44$ -0.46$ -0.73$ -0.86
Weighted Average Shares Outstanding
185.61M 165.96M 150.94M 106.24M 75.84M
Weighted Average Shares Outstanding (Diluted)
185.61M 165.96M 150.94M 106.24M 75.84M
Currency in USD

Arbutus Biopharma Earnings and Revenue History